Cancer HealthCast: NCI Program Unlocks Emerging Proteomic Data to Advance Precision Medicine
Researchers say sharing molecular cancer research data can expand cancer treatment and care.
Proteomics is an emerging field in cancer care and research. The National Cancer Institute’s Clinical Proteomic Tumor Analysis Consortium (CPTAC) aims to get to the heart of cancer by studying its molecular basis across different cancers. The group believes expanding open-source resources and other data can lead to new treatments in cancer and expand precision medicine.
Dr. Henry Rodriguez, the founding director of the Office of Cancer Clinical Proteomics Research at NCI, discusses the program and how the related International Cancer Proteogenome Consortium (ICPC) is helping researchers pull together resources necessary to innovate cancer care.
-
Dr. Henry Rodriguez Founding Director, Office of Cancer Clinical Proteomics Research NCI
-
TSA Scientists: Biometrics Advancements Require Legislation, Standards
Biometric advancements over the past decade have impressed researchers, who aim to achieve more as the technology evolves.
4m read -
CBP Considers Generative AI in Border Security Systems
The agency is weighing privacy protections amid advancements in identity processes and generative AI development.
4m read -
This FBI Database Made DNA Science a 'Factory' vs 'Boutique'
The FBI's Combined DNA Index System revolutionized how DNA and biometrics are collected and used in law enforcement.
4m read -
CBP's Digital Identity Plan Hones in on Advanced Biometrics Tech
The agency is testing biometrics and AI technology to speed up traveler experiences and processing times at points of entry.
3m read
